Background
Radical activists and the medical industry are targeting vulnerable children, convincing them and their families that puberty blockers, cross-sex hormones, and sex-rejecting procedures are necessary for kids struggling with gender dysphoria. These experimental procedures permanently damage children’s bodies, remove their ability to have children, and carry long-term physical and mental health consequences. Brave detransitioners, like Chloe Cole, have exposed the harsh reality of so-called “gender-affirming care.”
Yet this billion-dollar sex-rejecting industrial complex downplays these risks and exaggerates the benefits for profit. These interventions are marketed as safe, necessary, and reversible, but the truth is that children are being subjected to irreversible medical experiments for profit.
It’s unacceptable to sacrifice the health of children to this experimental and dangerous ideology, especially when up to 98% of children with gender dysphoria naturally accept their sex by adulthood.
The Chloe Cole Act of 2026 (H.R. 7651), introduced by Rep. Bob Onder (R-Missouri), would protect kids like Chloe Cole, who was given puberty blockers and testosterone starting at 13 and underwent a double mastectomy at 15. She has suffered countless complications and side-effects – all because of decisions her legal guardians made under pressure by the medical establishment.
This bill allows families to hold accountable the medical professionals, hospitals, and clinics responsible for giving these drugs and procedures to minors. By establishing a private right of action and extending the statute of limitations, families can sue and seek financial damages for the lasting harm caused by these experimental procedures – codifying the directive of President Trump’s Executive Order 14187.
Urge your representative to cosponsor the Chloe Cole Act of 2026 (H.R. 7651) to protect children from experimental, life-altering procedures and hold the medical institutions profiting from these interventions accountable.